Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

The free androgen index varies among women with different types of PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Increased oxidative stress and decreased antioxidants contribute to hair loss in androgenetic alopecia.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Clascoterone cream could be used for other skin conditions affected by hormones.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

Bald men may have a lower risk of testicular cancer.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.